Ophthalmologists: Will 2015 Make You or Break You?
Post# of 30028
Posted On: 01/30/2015 9:27:52 PM
Ophthalmologists: Will 2015 Make You or Break You?
January 30, 2015
Orphan drug approval. In December 2014, the US Food and Drug Administration (FDA) gave orphan drug approval to mesencephalic astrocyte-derived neurotrophic factor as a treatment for retinitis pigmentosa. The naturally occurring protein works by inhibiting apoptosis. "That's exciting because it's bringing cells back to life," says Dr Bhavsar.
http://www.medscape.com/viewarticle/838877
Dr. Abdhish Bhavsar, MD is a retina specialist and a clinical spokesman for the American Academy of Ophthalmology.
January 30, 2015
Orphan drug approval. In December 2014, the US Food and Drug Administration (FDA) gave orphan drug approval to mesencephalic astrocyte-derived neurotrophic factor as a treatment for retinitis pigmentosa. The naturally occurring protein works by inhibiting apoptosis. "That's exciting because it's bringing cells back to life," says Dr Bhavsar.
http://www.medscape.com/viewarticle/838877
Dr. Abdhish Bhavsar, MD is a retina specialist and a clinical spokesman for the American Academy of Ophthalmology.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼